A multi-step solvent-free mechanochemical route to indium(<scp>iii</scp>) complexes
作者:Jingyi Wang、Rakesh Ganguly、Li Yongxin、Jesus Díaz、Han Sen Soo、Felipe García
DOI:10.1039/c6dt00978f
日期:——
demonstrate that main-group indium(III) complexes featuring bis(imino)acenaphthene (BIAN) ligands are readily accessible through a mechanochemical milling approach. The synthetic methodology reported herein not only bypasses the use of large solvent quantities and transition metal reagents for ligand synthesis, but also reduces reaction times dramatically. These new main-group complexes exhibit the potential
The Effect of Aryl Substitution on the Properties of a Series of Highly Absorptive Cationic Iridium(III) Complexes Bearing Ancillary Bis(arylimino)acenaphthene Ligands
作者:Kamrul Hasan、Eli Zysman‐Colman
DOI:10.1002/ejic.201300583
日期:2013.9.2
A family of cationic heteroleptic iridium(III) complexes of the form [Ir(ppy)2(Ar-BIAN)]PF6 (ppyH = 2-phenylpyridine) in which Ar-BIAN [bis(arylimino)acenaphthene] acts as an ancillaryligand were synthesized and characterized. Their ground-state electronic structures were probed by UV/Vis spectroscopy and cyclic voltammetry. The X-ray structure of [Ir(ppy)2(4-MeO2CPh-BIAN)]PF6 was solved. The first
Van Asselt, Rob; Elsevier, Cornelis J.; Smeets, Wilberth J. J., Inorganic Chemistry, 1994, vol. 33, # 7, p. 1521 - 1531
作者:Van Asselt, Rob、Elsevier, Cornelis J.、Smeets, Wilberth J. J.、Spek, Anthony L.
DOI:——
日期:——
Knoer, Guenther; Leirer, Markus; Keyes, Tia E., European Journal of Inorganic Chemistry, 2000, # 4, p. 749 - 752
作者:Knoer, Guenther、Leirer, Markus、Keyes, Tia E.、Vos, Johannes G.、Vogler, Arnd
DOI:——
日期:——
Potent half-sandwich Ru(Ⅱ) N^N (aryl-BIAN) complexes: Lysosome-mediated apoptosis, in vitro and in vivo anticancer activities
作者:Zhishan Xu、Jie Huang、Deliang Kong、Yuliang Yang、Lihua Guo、Xianglei Jia、Genshen Zhong、Zhe Liu
DOI:10.1016/j.ejmech.2020.112763
日期:2020.12
Herein a new series of organometallic half-sandwich Ru(Ⅱ) complexes bearing aryl-BIAN chelating ligands with various electron-withdrawing and electron-donating substituents have been developed as theranostic agents. All the complexes display much higher anti-proliferative potency than the clinical chemotherapeutic drug cisplatin towards seven cancer cell lines. The anti-proliferative efficacy of these